Evidence map›Paper›PMID 41731805›Full record

ArticleMedicine2026

Prevalence and predictors of dry eye syndrome among the young population in Jordan: A cross-sectional survey study.

Dina M Abdulmannan, Abdallah Y Naser

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dina M AbdulmannanCollege of Medicine, Umm Alqura University, Makkah, Saudi Arabia.
Abdallah Y NaserDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman, Jordan.ORCID 0000-0001-8440-7446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dry eye syndrome (DES) is one of the leading causes of eye care visits. Research has shown that the prevalence of DES is higher in Asian populations than in Europeans and Americans. It poses a significant global burden, and with the increasing use of digital screens, particularly among the younger, the global burden of DES is anticipated to increase. This study aimed to investigate the prevalence and predictors of DES among the young population in Jordan. This was an online cross-sectional survey study that utilized Qualtrics survey software and was conducted in Jordan between November 2021 and January 2022. The National Eye Institute Visual Functioning Questionnaire-25 was utilized in this research. The prevalence of DES was estimated based on patients' self-reports. Dry eye is reported by 356 participants (32.4%). Regarding the overall health, 366 participants (32.5%) rate it as good, and 420 participants (37.3%) describe their vision as good. Regarding staying home due to eyesight, 2.3% strongly agreed, and 4.1% mostly agreed. Females showed higher odds of the developing DES compared to males (OR = 2.1, 95% CI:1.5-3.0, P = .04). Individuals having comorbidities exhibiting lower odds of developing DES (OR = 0.4, 95% CI: 0.3-0.6, P < .001). This study underscores that the prevalence of DES was moderate among young people in Jordan, with similarly prevalent eye irritation, which is the primary symptom of DES. A significant association was observed between DES and some factors, specifically female gender, which are possibly due to hormonal influences. These determinations may assist in developing management and prevention approaches for DES to enhance individuals' quality of life and reduce the economic burden. Further studies are needed to address the study limitations.

Indexed as

Dry Eye SyndromesAdolescentAdultCross-Sectional StudiesFemaleHumansJordanMalePrevalenceRisk FactorsSurveys and QuestionnairesYoung Adultdry eye syndromeeyehealthJordanprevalencevisionyouth

Identifiers

PMID41731805
PMCPMC12928936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.